0001613103Medtronic plcD02 XH02false00016131032023-12-062023-12-060001613103us-gaap:CommonStockMember2023-12-062023-12-060001613103mdt:SeniorNotes2019Due2025Member2023-12-062023-12-060001613103mdt:SeniorNotes2020Due2025Member2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2025Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due2027Member2023-12-062023-12-060001613103mdt:A2020SeniorNotesDue2028Member2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2028Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due20311.625PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2022Due20313125PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2031Member2023-12-062023-12-060001613103mdt:A2020SeniorNotesDue2032Member2023-12-062023-12-060001613103mdt:SeniorNotes2022Due2034Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due20392.250PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2019Due20391.50PercentMember2023-12-062023-12-060001613103mdt:SeniorNotes2020Due2040Member2023-12-062023-12-060001613103mdt:SeniorNotes2019Due2049Member2023-12-062023-12-060001613103mdt:SeniorNotes2020Due2050Member2023-12-062023-12-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 6, 2023
 _____________________________ 
Medtronic plc
(Exact Name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))













Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered
Ordinary Shares, $0.0001 par value per shareMDTNew York Stock Exchange
0.250% Senior Notes due 2025MDT/25New York Stock Exchange
0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange
2.625% Senior Notes due 2025MDT/25BNew York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
0.375% Senior Notes due 2028MDT/28New York Stock Exchange
3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange
3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange
0.750% Senior Notes due 2032MDT/32New York Stock Exchange
3.375% Senior Notes due 2034MDT/34New York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange
1.750% Senior Notes due 2049MDT/49New York Stock Exchange
1.625% Senior Notes due 2050MDT/50New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 8.01Other Events.
On May 25, 2023, Medtronic plc (Medtronic) announced that it had entered into a set of definitive agreements (Agreements) to acquire EOFlow Co. Ltd. (EOFlow) (KOSDAQ: 294090) pursuant to a share purchase agreement, a share subscription agreement, and a public tender offer, subject to the satisfaction of the minimum tender condition and certain customary closing conditions, including receipt of required regulatory clearances. On December 6, 2023, based upon multiple breaches under the Agreements, Medtronic delivered notice to EOFlow that it had exercised its right to terminate the Agreements. Medtronic does not believe any termination fee is payable under the Agreements. The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   Medtronic plc
Date: December 6, 2023  By /s/ Karen L. Parkhill
   Karen L. Parkhill
   Executive Vice President and Chief Financial Officer





v3.23.3
Document And Entity Information
Dec. 06, 2023
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Dec. 06, 2023
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One 20 On Hatch, Lower Hatch Street
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001613103
Entity Registrant Name Medtronic plc
Entity Address, Postal Zip Code D02 XH02
Amendment Flag false
Ordinary Shares, $0.0001 par value per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary Shares, $0.0001 par value per share
Trading Symbol MDT
Security Exchange Name NYSE
0.250% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.250% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
0.000% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2025
Trading Symbol MDT/25A
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
0.375% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2028
Trading Symbol MDT/28
Security Exchange Name NYSE
3.000% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.000% Senior Notes due 2028
Trading Symbol MDT/28A
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.000% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.000% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
0.750% Senior Notes due 2032  
Entity Information [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2032
Trading Symbol MDT/32
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.500% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.500% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.375% Senior Notes due 2040  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Senior Notes due 2040
Trading Symbol MDT/40A
Security Exchange Name NYSE
1.750% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.750% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE
1.625% Senior Notes due 2050  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2050
Trading Symbol MDT/50
Security Exchange Name NYSE
3.375% Senior Notes due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 3.375% Senior Notes due 2034
Trading Symbol MDT/34
Security Exchange Name NYSE
3.125% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 3.125% Senior Notes due 2031
Trading Symbol MDT/31B
Security Exchange Name NYSE
2.625% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 2.625% Senior Notes due 2025
Trading Symbol MDT/25B
Security Exchange Name NYSE

Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Medtronic Charts.